ArticleLeukemia2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.
F E Bertrand et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it